The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Anticancer carbonic anhydrase inhibitors: a patent review (2008 – 2013)
Open accessAbstract
INTRODUCTION: Human carbonic anhydrases (EC 4.2.1.1) IX (hCA IX) and XII (hCA XII) are two tumor-associated proteins, being overexpressed in many tumors and involved in critical processes associated with cancer progression and response to therapy. Both are multi-domain proteins consisting of an extracellular catalytic domain (CA), a transmembrane portion (TM) and an intracytoplasmic (IC) segment. These domains have peculiar biochemical and physiological features. CA IX contains an additional proteoglycan-like (PG) domain at the N-terminus which constitutes a unique feature of this enzyme within the CA family. AREAS COVERED: Starting from a brief description of the main molecular and catalytic features of both enzymes, their role in tumor physiology and their three-dimensional structure, this review describes the main classes of small molecule inhibitors, investigated between 2008 and 2013, able to inhibit these enzymes for both diagnostic and therapeutic applications. EXPERT OPINION: A consistent number of patents on molecules able to inhibit the catalytic activity of CA IX and CA XII have been recently reported. Most patents deal with classical sulfonamide derivatives, demonstrating that introducing suitable substituents on the inhibitor scaffold, good selectivity can be obtained. However, the most impressive results are related to compounds containing novel chemotypes, such as coumarins and thiocumarins. Thus, it is expected that research in next future will be more dedicated to the development of molecules containing new chemotypes and a large number of studies in such field have already been published demonstrating the role of these enzymes in carcinogenesis and metastases formation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
Supuran, C. T. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2467 · Cited by 3,192
Self-citationHypoxia-inducible expression of tumor-associated carbonic anhydrases.
Wykoff, C. C., Beasley, N. J. P., Watson, P. H., Turner, K., Pastorek, J., Sibtain, A., Wilson, G. D., Turley, H., Talks, K., Maxwell, P. H., et al. (2000) · PubMed · Cited by 1,491
Supuran, C. T., Scozzafava, A., & Casini, A. (2003) · Medicinal Research Reviews · doi:10.1002/med.10025 · Cited by 1,449
Self-citationAlterio, V., Di Fiore, A., D’Ambrosio, K., Supuran, C. T., & De Simone, G. (2012) · Chemical Reviews · doi:10.1021/cr200176r · Cited by 1,238
Self-citationCauses and consequences of tumour acidity and implications for treatment
Stubbs, M., McSheehy, P. M. J., Griffiths, J. R., & Bashford, C. L. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01615-9 · Cited by 778
Lou, Y., McDonald, P. C., Oloumi, A., Chia, S., Ostlund, C., Ahmadi, A., Kyle, A., auf dem Keller, U., Leung, S., Huntsman, D., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4261 · Cited by 755
Self-citationChiche, J., Ilc, K., Laferrière, J., Trottier, E., Dayan, F., Mazure, N. M., Brahimi-Horn, M. C., & Pouysségur, J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2470 · Cited by 750
Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH
Švastová, E., Hulı́ková, A., Rafajová, M., Zat'ovičová, M., Gibadulinová, A., Casini, A., Cecchi, A., Scozzafava, A., Supuran, C. T., Pastorek, J., et al. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.10.043 · Cited by 711
Self-citationExpression of Hypoxia-Inducible Cell-Surface Transmembrane Carbonic Anhydrases in Human Cancer
Ivanov, S., Liao, S.-Y., Ivanova, A., Danilkovitch-Miagkova, A., Tarasova, N., Weirich, G., Merrill, M. J., Proescholdt, M. A., Oldfield, E. H., Lee, J., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64038-2 · Cited by 679
Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer
Chiche, J., Brahimi‐Horn, M. C., & Pouysségur, J. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00994.x · Cited by 667
Supuran, C. T. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.05.009 · Cited by 616
Self-citationTumor microenvironment abnormalities: Causes, consequences, and strategies to normalize
Fukumura, D., & Jain, R. K. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21187 · Cited by 584
Regulation of tumor pH and the role of carbonic anhydrase 9
Swietach, P., Vaughan-Jones, R. D., & Harris, A. L. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9064-0 · Cited by 539 · cited 4×
“PG domain It is involved in cell adhesion and intercellular communication [24-26] and supports CA domain-mediated catalysis at the acidic pH where CA IX is overexpressed [27,28] Catalytic domain It is fundamentally involved in pH regulation of the tumor cells, thus allowing their growth and survival [7,17] IC tail It…”
BackgroundInfluentialNon-Zinc Mediated Inhibition of Carbonic Anhydrases: Coumarins Are a New Class of Suicide Inhibitors
Maresca, A., Temperini, C., Vu, H., Pham, N. B., Poulsen, S.-A., Scozzafava, A., Quinn, R. J., & Supuran, C. T. (2009) · Journal of the American Chemical Society · doi:10.1021/ja809683v · Cited by 521
Self-citationCrystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX
Alterio, V., Hilvo, M., Di Fiore, A., Supuran, C. T., Pan, P., Parkkila, S., Scaloni, A., Pastorek, J., Pastorekova, S., Pedone, C., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908301106 · Cited by 521
Self-citationPacchiano, F., Carta, F., McDonald, P. C., Lou, Y., Vullo, D., Scozzafava, A., Dedhar, S., & Supuran, C. T. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101541x · Cited by 519
Self-citationPastorek, J., Pastoreková, S., Callebaut, I., Mornon, J., Zelnı́k, V., Opavský, R., Zaťovičová, M., Liao, S., Portetelle, D., & Stanbridge, E. J. (1994) · PubMed · Cited by 509
Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism.
Helmlinger, G., Sckell, A., Dellian, M., Forbes, N. S., & Jain, R. K. (2002) · PubMed · Cited by 417
Deciphering the Mechanism of Carbonic Anhydrase Inhibition with Coumarins and Thiocoumarins
Maresca, A., Temperini, C., Pochet, L., Masereel, B., Scozzafava, A., & Supuran, C. T. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901287j · Cited by 402
Self-citationIvanov, S. V., Kuzmin, I., Wei, M.-H., Pack, S., Geil, L., Johnson, B. E., Stanbridge, E. J., & Lerman, M. I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12596 · Cited by 399
Targeting tumor-associated carbonic anhydrase IX in cancer therapy
Thiry, A., Dogné, J.-M., Masereel, B., & Supuran, C. T. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.09.002 · Cited by 395
Self-citationOpavský, R., Pastoreková, S., Zelnı́k, V., Gibadulinová, A., Stanbridge, E. J., Závada, J., Kettmann, R., & Pastorek, J. (1996) · Genomics · doi:10.1006/geno.1996.0223 · Cited by 384
Türeci, Ö., Sahin, U., Vollmar, E., Siemer, S., Göttert, E., Seitz, G., Parkkila, A.-K., Shah, G. N., Grubb, J. H., Pfreundschuh, M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7608 · Cited by 360
Carbonic Anhydrase: Its Inhibitors and Activators
Supuran, C. T., Scozzafava, A., & Conway, J. D. (2007) · Medical Entomology and Zoology · Cited by 350
Self-citationTargeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche
Lock, F. E., McDonald, P. C., Lou, Y., Serrano, I., Chafe, S. C., Ostlund, C., Aparicio, S., Winum, J.-Y., Supuran, C. T., & Dedhar, S. (2013) · Oncogene · doi:10.1038/onc.2012.550 · Cited by 348
Self-citationWhittington, D. A., Waheed, A., Ulmasov, B., Shah, G. N., Grubb, J. H., Sly, W. S., & Christianson, D. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161301298 · Cited by 335
Biochemical Characterization of CA IX, One of the Most Active Carbonic Anhydrase Isozymes
Hilvo, M., Baranauskiene, L., Salzano, A. M., Scaloni, A., Matulis, D., Innocenti, A., Scozzafava, A., Monti, S. M., Di Fiore, A., De Simone, G., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800938200 · Cited by 307
Self-citationPotter, C., & Harris, A. L. (2004) · Cell Cycle · doi:10.4161/cc.3.2.618 · Cited by 279
Wykoff, C. C., Beasley, N., Watson, P. H., Campo, L., Chia, S. K., English, R., Pastorek, J., Sly, W. S., Ratcliffe, P., & Harris, A. L. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64048-5 · Cited by 249
Švastová, E., Žilka, N., Zat'ovičová, M., Gibadulinová, A., Čiampor, F., Pastorek, J., & Pastoreková, S. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00351-3 · Cited by 239
Carbonic Anhydrase IX in Renal Cell Carcinoma: Implications for Prognosis, Diagnosis, and Therapy
Stillebroer, A. B., Mulders, P. F. A., Boerman, O. C., Oyen, W. J. G., & Oosterwijk, E. (2010) · European Urology · doi:10.1016/j.eururo.2010.03.015 · Cited by 238
Sulfonamides: a patent review (2008 – 2012)
Carta, F., Scozzafava, A., & Supuran, C. T. (2012) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2012.698264 · Cited by 234
Self-citationCecchi, A., Hulikova, A., Pastorek, J., Pastoreková, S., Scozzafava, A., Winum, J.-Y., Montero, J.-L., & Supuran, C. T. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0501073 · Cited by 217
Self-citationPacchiano, F., Aggarwal, M., Avvaru, B. S., Robbins, A. H., Scozzafava, A., McKenna, R., & Supuran, C. T. (2010) · Chemical Communications · doi:10.1039/c0cc02707c · Cited by 217
Self-citationCarbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target
De Simone, G., & Supuran, C. T. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.07.027 · Cited by 213
Self-citationDubois, L., Lieuwes, N. G., Maresca, A., Thiry, A., Supuran, C. T., Scozzafava, A., Wouters, B. G., & Lambin, P. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.06.019 · Cited by 198
Self-citationHussain, S. A., Ganesan, R., Reynolds, G., Gross, L., Stevens, A., Pastorek, J., Murray, P. G., Perunovic, B., Anwar, M. S., Billingham, L., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603530 · Cited by 194
Drug design of Zinc-enzyme inhibitors: functional, structural and disease applications
Supuran, C. T., & Winum, J. (2009) · HAL (Le Centre pour la Communication Scientifique Directe) · Cited by 193
Self-citationCancer-Associated Carbonic Anhydrases and Their Inhibition
Pastorek, J., Pastorekova, S., & Zatovicova, M. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208783877893 · Cited by 187
Závada, J., Závadová, Z., Pastorek, J., Biesová, Z., Jez˘ek, J., & Velek, J. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1111 · Cited by 170
The role of carbonic anhydrase IX overexpression in kidney cancer
Dorai, T., Sawczuk, I. S., Pastorek, J., Wiernik, P. H., & Dutcher, J. P. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.09.011 · Cited by 163
Modulation of carbonic anhydrase activity and its applications in therapy
Scozzafava, A., Mastrolorenzo, A., & Supuran, C. T. (2004) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.14.5.667 · Cited by 163
Self-citationTumor‐associated Carbonic Anhydrases and Their Clinical Significance
(2006) · Advances in Clinical Chemistry · doi:10.1016/s0065-2423(06)42005-9 · Cited by 162
Maresca, A., Scozzafava, A., & Supuran, C. T. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.10.094 · Cited by 161
Self-citationDubois, L. J., Douma, K., Supuran, C. T., Chiu, R. K., van Zandvoort, M. A. M. J., Pastoreková, S., Scozzafava, A., Wouters, B. G., & Lambin, P. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.04.018 · Cited by 154
Self-citationDitte, P., Dequiedt, F., Švastová, E., Hulíková, A., Ohradanova‐Repic, A., Zaťovičová, M., Csáderová, L., Kopáček, J., Supuran, C. T., Pastoreková, S., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2520 · Cited by 152
Self-citationPastoreková, S., Casini, A., Scozzafava, A., Vullo, D., Pastorek, J., & Supuran, C. T. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.12.029 · Cited by 150
Self-citationScozzafava, A., Briganti, F., Ilies, M. A., & Supuran, C. T. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990479+ · Cited by 146
Self-citationMaresca, A., & Supuran, C. T. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.06.040 · Cited by 144
Self-citationDirect Screening of Natural Product Extracts Using Mass Spectrometry
Vu, H., Pham, N. B., & Quinn, R. J. (2008) · SLAS DISCOVERY · doi:10.1177/1087057108315739 · Cited by 131
Hypoxia in cancer cell metabolism and pH regulation
Brahimi-Horn, M. C., & Pouysségur, J. (2007) · Essays in Biochemistry · doi:10.1042/bse0430165 · Cited by 123
Pastoreková, S., Casini, A., Scozzafava, A., Vullo, D., Pastorek, J., & Supuran, C. T. (2004) · ChemInform · doi:10.1002/chin.200425244 · Cited by 118
Self-citationHsieh, M., Chen, K.-S., Chiou, H., & Hsieh, Y. (2010) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2010.03.004 · Cited by 110
Haapasalo, J. A., Hilvo, M., Nordfors, K., Haapasalo, H. K., Parkkila, S., Hyrskyluoto, A., Rantala, I. S., Waheed, A., Sly, W. S., Pastoreková, S., et al. (2008) · Neuro-Oncology · doi:10.1215/15228517-2007-065 · Cited by 109
Ilié, M., Hofman, V., Ortholan, C., Ammadi, R. E., Bonnetaud, C., Havet, K., Vénissac, N., Mouroux, J., Mazure, N. M., Pouysségur, J., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25491 · Cited by 108
Lee, A. H., & Tannock, I. F. (1998) · PubMed · Cited by 104
Expression of transmembrane carbonic anhydrases IX and XII in ovarian tumours
Hynninen, P., Vaskivuo, L., Saarnio, J., Haapasalo, H. K., Kivelä, J., Pastoreková, S., Pastorek, J., Waheed, A., Sly, W. S., Puistola, U., et al. (2006) · Histopathology · doi:10.1111/j.1365-2559.2006.02523.x · Cited by 101
Lee, H. S., Bae, T., Lee, J., Kim, D. G., Oh, Y. S., Jang, Y., Kim, J.-T., Lee, J.-J., Innocenti, A., Supuran, C. T., et al. (2012) · BMC Systems Biology · doi:10.1186/1752-0509-6-80 · Cited by 89
Self-citationBattke, C., Kremmer, E., Mysliwietz, J., Gondi, G., Dumitru, C. A., Brandau, S., Lang, S., Vullo, D., Supuran, C. T., & Zeidler, R. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-0980-z · Cited by 81
Self-citationInnocenti, A., Pastoreková, S., Pastorek, J., Scozzafava, A., Simone, G. D., & Supuran, C. T. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.08.088 · Cited by 76
Self-citationParkkila, S., Innocenti, A., Kallio, H. M. L., Hilvo, M., Scozzafava, A., & Supuran, C. T. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.06.002 · Cited by 69
Self-citationCarbonic Anhydrases: Catalytic and Inhibition Mechanisms, Distribution and Physiological Roles
Supuran, C. T. (2004) · doi:10.1201/9780203475300-5 · Cited by 65
Self-citationCarbonic Anhydrase IX as a Target for Designing Novel Anticancer Drugs
Monti, S. M., Supuran, C. T., & Simone, G. D. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712799034851 · Cited by 54
Self-citationKivela, A.-J. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i17.2616 · Cited by 54
Buanne, P., Renzone, G., Monteleone, F., Vitale, M., Monti, S. M., Sandomenico, A., Garbi, C., Montanaro, D., Accardo, M., Troncone, G., et al. (2012) · Journal of Proteome Research · doi:10.1021/pr300565w · Cited by 51
Self-citationSupuran, C. T., Fiore, A. D., Alterio, V., Monti, S. M., & Simone, G. D. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210793429841 · Cited by 40
Self-citationHulı́ková, A., Zaťovičová, M., Švastová, E., Ditte, P., Brasseur, R., Kettmann, R., Supuran, C. T., Kopáček, J., Pastorek, J., & Pastoreková, S. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.10.060 · Cited by 36
Self-citationPastoreková, S., Baráthová, M., Kopáček, J., & Pastorek, J. (2009) · Wiley eBooks · doi:10.1002/9780470508169.ch8 · Cited by 6
Cited by
Structure and function of carbonic anhydrases
Supuran, C. T. (2016) · Biochemical Journal · doi:10.1042/bcj20160115 · Cited by 922
Self-citationHow many carbonic anhydrase inhibition mechanisms exist?
Supuran, C. T. (2016) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2015.1122001 · Cited by 737
Self-citationSupuran, C. T., Alterio, V., Di Fiore, A., D’ Ambrosio, K., Carta, F., Monti, S. M., & De Simone, G. (2018) · Medicinal Research Reviews · doi:10.1002/med.21497 · Cited by 253
Self-citation
Metadata
- Authors
- Monti, S. M., Supuran, C. T., & De Simone, G.
- Venue
- Expert Opinion on Therapeutic Patents
- Publisher
- Informa UK Limited
- Published
- 2013-05-15
- Volume
- 23
- Issue
- 6
- Pages
- 737-749
- ISSN
- 1354-3776 (ISSN-L)
- 1744-7674
- OpenAlex
- W1981283595
- Cited by
- 265
- References
- 68
- FWCI
- 12.10
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.